 Autologous bone marrow transplantation patients history low-grade B-cell non-Hodgkin lymphoma Sixty-nine patients history low-grade B-cell non-Hodgkin lymphoma NHL sensitive relapse incomplete first remission underwent high-dose chemoradiotherapy anti-B-cell monoclonal antibody MoAb autologous bone marrow transplantation ABMT ABMT patients low-grade histology patients history low-grade NHL undergone histologic transformation higher-grade NHL ABMT low-grade patients patients transformed histologies complete remission time marrow harvest low-grade transformed histology patients histologic evidence lymphoma cells marrow high-dose therapy acute in-hospital death significant difference disease-free survival DFS patients low-grade patients transformed histologies patients low-grade NHL patients complete remission ABMT DFS partial remission preliminary study patients relapsed low-grade NHL prolonged DFS high-dose ablative therapy